TMC4 inhibitors are a class of chemical compounds designed to specifically target and inhibit the activity of the TMC4 protein, a member of the transmembrane channel-like family involved in ion transport and cellular signaling pathways. These inhibitors work by binding to key regions of the TMC4 protein, often targeting the active site or functional domains that are crucial for its role in facilitating ion passage or signal transduction across the membrane. By occupying these regions, TMC4 inhibitors block the protein's interaction with its natural substrates or ions, effectively disrupting its normal role in cellular processes. In addition to binding at the active site, some TMC4 inhibitors may act through allosteric mechanisms, where they attach to other parts of the protein that induce conformational changes, leading to reduced or inhibited protein function. The interaction between TMC4 inhibitors and the protein is often stabilized by non-covalent forces such as hydrogen bonds, van der Waals interactions, hydrophobic contacts, and electrostatic interactions, which help to ensure the stability and effectiveness of the inhibitor-protein complex.
Structurally, TMC4 inhibitors exhibit a wide range of chemical diversity, allowing for precise and specific interactions with different regions of the TMC4 protein. These inhibitors typically contain functional groups such as hydroxyl, carboxyl, or amine groups, which facilitate the formation of hydrogen bonds and ionic interactions with amino acid residues in the protein's binding pockets. Additionally, many TMC4 inhibitors feature aromatic rings and heterocyclic structures, which enhance hydrophobic interactions with non-polar regions of the protein, further stabilizing the inhibitor-protein complex. The physicochemical properties of these inhibitors, including molecular weight, solubility, lipophilicity, and polarity, are carefully optimized to ensure they remain effective and stable in various biological environments. By balancing hydrophilic and hydrophobic regions, TMC4 inhibitors can selectively interact with both polar and non-polar areas of the protein, ensuring robust and efficient inhibition of TMC4 function across different cellular conditions.
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
This DNA methyltransferase inhibitor could cause hypomethylation of the TMC4 gene promoter, leading to a reduction in its transcription efficiency. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
By inhibiting histone deacetylases, this compound may promote a more closed chromatin state at the TMC4 locus, thereby decreasing transcriptional activity. | ||||||
RG 108 | 48208-26-0 | sc-204235 sc-204235A | 10 mg 50 mg | $131.00 $515.00 | 2 | |
This inhibitor could prevent methylation of the TMC4 promoter DNA, potentially leading to a decrease in the initiation of transcription of the TMC4 gene. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $218.00 $322.00 $426.00 | 7 | |
By interfering with DNA methylation, 5-Aza-2′-Deoxycytidine could lead to a decrease in TMC4 gene expression through the disruption of transcriptional repression. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Actinomycin D intercalates into DNA, which could inhibit RNA polymerase from accessing the TMC4 gene, resulting in a decrease in TMC4 mRNA synthesis. | ||||||
α-Amanitin | 23109-05-9 | sc-202440 sc-202440A | 1 mg 5 mg | $269.00 $1050.00 | 26 | |
This compound could inhibit RNA polymerase II activity, leading to a direct decrease in the transcription of the TMC4 gene and subsequent mRNA levels. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
As an mTOR inhibitor, rapamycin could suppress the translation of TMC4 mRNA by disrupting downstream signaling pathways that control protein synthesis. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $41.00 $84.00 $275.00 | 127 | |
This eukaryotic protein synthesis inhibitor could prevent the ribosomal translation of TMC4 mRNA, leading to a reduction in TMC4 protein levels. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
By inhibiting the PI3K/Akt pathway, this compound could downregulate the transcriptional machinery responsible for expressing the TMC4 gene. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
As a JNK inhibitor, SP600125 could decrease TMC4 expression by preventing activation of transcription factors that are crucial for the transcription of TMC4. | ||||||